{"id":4898,"date":"2018-03-07T09:00:00","date_gmt":"2018-03-07T09:00:00","guid":{"rendered":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/"},"modified":"2024-09-23T11:22:34","modified_gmt":"2024-09-23T11:22:34","slug":"toch-geen-type-1-diabetes","status":"publish","type":"post","link":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/","title":{"rendered":"Toch geen Type 1 Diabetes?"},"content":{"rendered":"\"\"<\/a>In het algemeen wordt er gesproken van type 1 of type 2 diabetes. Daarnaast bestaan er nog een aantal minder frequent voorkomende vormen van diabetes, zoals MODY, LADA en MIDD. Er wordt geschat dat ongeveer 90% van de mensen met diabetes type 2 diabetes heeft en zo\u2019n 10% Type 1 Diabetes.\n\nUit een onderzoek dat recent gepubliceerd is in het tijdschrift \u201cThe Lancet\u201d blijkt echter dat het onderscheiden van type 1 en type 2 diabetes niet voldoende is en er hoogstwaarschijnlijk niet twee, maar vijf subgroepen van diabetes mellitus bestaan. Dit is geconstateerd na het onderzoeken van bijna 9000 mensen uit Zweden die recent, op volwassen leeftijd, gediagnosticeerd waren met diabetes. Er werd bij het onderzoek gekeken naar verschillen in antistoffen, leeftijd bij diagnose, BMI, HbA1c en parameters voor insulineresistentie en b\u00e8tacelfunctie.\n\nEr werden hierbij vijf nieuwe subgroepen gevonden waarbij pati\u00ebnten van \u00e9\u00e9n subgroep veel dezelfde kenmerken vertoonden en ook meer risico liepen op \u00e9\u00e9n bepaalde complicatie. Zo liepen pati\u00ebnten uit cluster 2 meer risico op oogschade, waar cluster 3 pati\u00ebnten vaker nierschade opliepen.\n\n \n
Cluster<\/strong><\/td>\nPercentage mensen<\/strong><\/td>\nKenmerken<\/strong><\/td>\n<\/tr>
1<\/strong><\/td>\n5-15%<\/td>\nErnstige, auto-immune variant van diabetes. Lijkt het meest op wat we nu type 1 diabetes noemen.<\/td>\n<\/tr>
2<\/strong><\/td>\n9-20%<\/td>\nRelatief jonge pati\u00ebnten met insulinedefici\u00ebntie. Produceren weinig insuline en hebben matige insulineresistentie. Groot risico op diabetes-gerelateerde oogschade (retinopathie).<\/td>\n<\/tr>
3<\/strong><\/td>\n11-17%<\/td>\nPati\u00ebnten hebben vaak obesitas en ernstige insulineresistentie. Grote kans op diabetes-gerelateerde nierschade (nefropathie).<\/td>\n<\/tr>
4<\/strong><\/td>\n18-23%<\/td>\nPati\u00ebnten die ten tijde van diagnose jong waren en overgewicht hadden. Vaak geen insulineresistentie.<\/td>\n<\/tr>
5<\/strong><\/td>\n34-47%<\/td>\nEen milde vorm van diabetes die zich met name ontwikkeld bij ouderen.<\/td>\n<\/tr><\/tbody><\/table>\nEen dergelijke nieuwe indeling zal met name consequenties hebben voor mensen die op dit moment gediagnosticeerd zijn met type 2 diabetes, aangezien daar de meeste variatie te vinden was, maar ook sommige mensen die de diagnose type 1 diabetes hebben vallen eigenlijk onder een andere subgroep. Door het verder onderscheiden van verschillende clusters kunnen behandelingen worden aangepast, bijvoorbeeld door vaker te screenen op bepaalde complicaties in een bepaald cluster, zodat deze zoveel mogelijk voorkomen kunnen worden.\n\nDit onderzoek werd onder andere gefinancierd door het Innovative Medicines Initiative, waar Breakthrough T1D al vanaf het begin van de oprichting bij betrokken is. Breakthrough T1D bestuurslid Johan Keurentjes maakt deel uit van het pati\u00ebntenpanel van IMI.\n\n

Wil jij altijd op de hoogte gehouden worden van alle onderzoeken en ontwikkelingen rond Type 1 Diabetes? Meld je aan voor onze nieuwsbrief.<\/a><\/h3>","protected":false,"raw":""},"excerpt":{"rendered":"

In het algemeen wordt er gesproken van type 1 of type 2 diabetes. Daarnaast bestaan er nog een aantal minder frequent voorkomende vormen van diabetes, zoals MODY, LADA en MIDD. Er wordt geschat dat ongeveer 90% van de mensen met diabetes type 2 diabetes heeft en zo\u2019n 10% Type 1 Diabetes. Uit een onderzoek dat […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[184,187],"tags":[],"class_list":["post-4898","post","type-post","status-publish","format-standard","hentry","category-archief","category-behandelen"],"yoast_head":"\nToch geen Type 1 Diabetes? - Breakthrough T1D<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/\" \/>\n<meta property=\"og:locale\" content=\"nl_NL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Toch geen Type 1 Diabetes? - Breakthrough T1D\" \/>\n<meta property=\"og:description\" content=\"In het algemeen wordt er gesproken van type 1 of type 2 diabetes. Daarnaast bestaan er nog een aantal minder frequent voorkomende vormen van diabetes, zoals MODY, LADA en MIDD. Er wordt geschat dat ongeveer 90% van de mensen met diabetes type 2 diabetes heeft en zo\u2019n 10% Type 1 Diabetes. Uit een onderzoek dat […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/\" \/>\n<meta property=\"og:site_name\" content=\"Breakthrough T1D\" \/>\n<meta property=\"article:published_time\" content=\"2018-03-07T09:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-23T11:22:34+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/research-klein.jpg\" \/>\n<meta name=\"author\" content=\"ylt-admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Geschreven door\" \/>\n\t<meta name=\"twitter:data1\" content=\"ylt-admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Geschatte leestijd\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/\"},\"author\":{\"name\":\"ylt-admin\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\"},\"headline\":\"Toch geen Type 1 Diabetes?\",\"datePublished\":\"2018-03-07T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:34+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/\"},\"wordCount\":394,\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/research-klein.jpg\",\"articleSection\":[\"Archief\",\"Behandelen\"],\"inLanguage\":\"nl-NL\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/\",\"name\":\"Toch geen Type 1 Diabetes? - Breakthrough T1D\",\"isPartOf\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/research-klein.jpg\",\"datePublished\":\"2018-03-07T09:00:00+00:00\",\"dateModified\":\"2024-09-23T11:22:34+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/#breadcrumb\"},\"inLanguage\":\"nl-NL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/#primaryimage\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/research-klein.jpg\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/research-klein.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/breakthrought1d.eu\/nl\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Toch geen Type 1 Diabetes?\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#website\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"name\":\"Breakthrough T1D\",\"description\":\"Wij zetten ons in voor een toekomst zonder T1D\",\"publisher\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"nl-NL\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#organization\",\"name\":\"Breakthrough T1D\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"contentUrl\":\"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png\",\"width\":330,\"height\":141,\"caption\":\"Breakthrough T1D\"},\"image\":{\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6\",\"name\":\"ylt-admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"nl-NL\",\"@id\":\"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g\",\"caption\":\"ylt-admin\"},\"sameAs\":[\"https:\/\/87.250.144.92\"],\"url\":\"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Toch geen Type 1 Diabetes? - Breakthrough T1D","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/","og_locale":"nl_NL","og_type":"article","og_title":"Toch geen Type 1 Diabetes? - Breakthrough T1D","og_description":"In het algemeen wordt er gesproken van type 1 of type 2 diabetes. Daarnaast bestaan er nog een aantal minder frequent voorkomende vormen van diabetes, zoals MODY, LADA en MIDD. Er wordt geschat dat ongeveer 90% van de mensen met diabetes type 2 diabetes heeft en zo\u2019n 10% Type 1 Diabetes. Uit een onderzoek dat […]","og_url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/","og_site_name":"Breakthrough T1D","article_published_time":"2018-03-07T09:00:00+00:00","article_modified_time":"2024-09-23T11:22:34+00:00","og_image":[{"url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/research-klein.jpg","type":"","width":"","height":""}],"author":"ylt-admin","twitter_card":"summary_large_image","twitter_misc":{"Geschreven door":"ylt-admin","Geschatte leestijd":"2 minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/#article","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/"},"author":{"name":"ylt-admin","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6"},"headline":"Toch geen Type 1 Diabetes?","datePublished":"2018-03-07T09:00:00+00:00","dateModified":"2024-09-23T11:22:34+00:00","mainEntityOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/"},"wordCount":394,"publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/research-klein.jpg","articleSection":["Archief","Behandelen"],"inLanguage":"nl-NL"},{"@type":"WebPage","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/","url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/","name":"Toch geen Type 1 Diabetes? - Breakthrough T1D","isPartOf":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#website"},"primaryImageOfPage":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/#primaryimage"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/#primaryimage"},"thumbnailUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/research-klein.jpg","datePublished":"2018-03-07T09:00:00+00:00","dateModified":"2024-09-23T11:22:34+00:00","breadcrumb":{"@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/#breadcrumb"},"inLanguage":"nl-NL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/"]}]},{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/#primaryimage","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/research-klein.jpg","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/09\/research-klein.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/toch-geen-type-1-diabetes\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/breakthrought1d.eu\/nl\/"},{"@type":"ListItem","position":2,"name":"Toch geen Type 1 Diabetes?"}]},{"@type":"WebSite","@id":"https:\/\/breakthrought1d.eu\/nl\/#website","url":"https:\/\/breakthrought1d.eu\/nl\/","name":"Breakthrough T1D","description":"Wij zetten ons in voor een toekomst zonder T1D","publisher":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/breakthrought1d.eu\/nl\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"nl-NL"},{"@type":"Organization","@id":"https:\/\/breakthrought1d.eu\/nl\/#organization","name":"Breakthrough T1D","url":"https:\/\/breakthrought1d.eu\/nl\/","logo":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/","url":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","contentUrl":"https:\/\/breakthrought1d.eu\/nl\/wp-content\/uploads\/2024\/11\/BTlogo.png","width":330,"height":141,"caption":"Breakthrough T1D"},"image":{"@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/c141fde9814deb17e9eb392bdb6619a6","name":"ylt-admin","image":{"@type":"ImageObject","inLanguage":"nl-NL","@id":"https:\/\/breakthrought1d.eu\/nl\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/67a3317a8082bc0f586c2e46f82a1617530cf674f2027a1a7d60fdff63a2c3e8?s=96&d=mm&r=g","caption":"ylt-admin"},"sameAs":["https:\/\/87.250.144.92"],"url":"https:\/\/breakthrought1d.eu\/nl\/nieuws\/author\/ylt-admin\/"}]}},"_links":{"self":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/4898","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/comments?post=4898"}],"version-history":[{"count":5,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/4898\/revisions"}],"predecessor-version":[{"id":8917,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/posts\/4898\/revisions\/8917"}],"wp:attachment":[{"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/media?parent=4898"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/categories?post=4898"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/breakthrought1d.eu\/nl\/wp-json\/wp\/v2\/tags?post=4898"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}